Fig. 1
From: Hospital-based headache care during the Covid-19 pandemic in Denmark and Norway
Botulinum toxin A (BTX) treatment in Denmark (white) and Norway (black) during the lockdown. Respondents replied to the question “Did your Department continue botulinum toxin treatment for chronic migraine during the pandemic?”